Bristol-Myers Squibb Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 20,597.0 | 19,348.0 | 17,914.0 |
| Cost of Goods Sold | 6,396.0 | 6,218.0 | 5,956.0 |
| Gross Profit | 14,201.0 | 13,130.0 | 11,958.0 |
| Gross Profit Margin | 68.9% | 67.9% | 66.8% |
| SG&A Expense | 6,375.0 | 6,320.0 | 6,270.0 |
| Depreciation & Amortization | 816.0 | 892.0 | 927.0 |
| Operating Income | 5,781.0 | 3,956.0 | 3,133.0 |
| Operating Margin | 28.1% | 20.4% | 17.5% |
| Nonoperating Income | 1,660.0 | (364.0) | 0.0 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 5,471.0 | 3,534.0 | 2,635.0 |
| Income Taxes | 1,320.0 | 803.0 | 610.0 |
| Net Income After Taxes | 4,151.0 | 2,731.0 | 2,025.0 |
| Continuing Operations | 3,155.0 | 1,968.0 | 1,585.0 |
| Discontinued Operations | 2,092.0 | 197.0 | 0.0 |
| Total Operations | 5,247.0 | 2,165.0 | 1,585.0 |
| Total Net Income | 5,247.0 | 2,165.0 | 1,585.0 |
| Net Profit Margin | 25.5% | 11.2% | 8.8% |
| Diluted EPS from Total Net Income ($) | 2.63 | 1.09 | 0.81 |
| Dividends per Share | 1.24 | 1.15 | 1.12 |
© 2009 Morningstar, Inc. Financial Data provided by
